Prevalence of breakthrough cancer pain: A systematic review and a pooled analysis of published literature

Journal of Pain and Symptom Management

Volumn 47, Issue 1, 2014, Pages 57-76

  Deandrea, Silvia ^a,b   Corli, Oscar ^a   Consonni, Dario ^c   Villani, Walter ^a   Greco, Maria Teresa ^b   Apolone, Giovanni ^d  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d S MARIA NUOVA HOSPITAL   (Italy)

Author keywords

Breakthrough cancer pain; pooled analysis; prevalence; systematic review

Indexed keywords

ARTICLE; BREAKTHROUGH CANCER PAIN; CANCER PAIN; CANCER PATIENT; EMBASE; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MEDLINE; METASTASIS; PREVALENCE; SYSTEMATIC REVIEW; BREAKTHROUGH PAIN; META ANALYSIS; NEOPLASMS; PATHOPHYSIOLOGY;

BREAKTHROUGH PAIN; HUMANS; NEOPLASMS; PREVALENCE;

EID: 84891832560     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2013.02.015     Document Type: Review

References (58)

1. A.N. Davies, A. Dickman, C. Reid Science Committee of the Association for Palliative Medicine of Great Britain and Ireland The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland Eur J Pain 13 2009 331 338
2. A. Caraceni, G. Hanks, S. Kaasa European Palliative Care Research Collaborative (EPCRC), on behalf of the European Association for Palliative Care (EAPC) Use of opioid analgesic in the treatment of the cancer pain: evidence-based recommendations from the EAPC Lancet Oncol 13 2012 e58 e68
3. S. Mercadante, L. Radbruch, and A. Davies et al. A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomized, crossover trial Curr Med Res Opin 25 2009 2805 2815
4. R.L. Rauck, M. Tark, and E. Reyes et al. Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain Curr Med Res Opin 25 2009 2877 2885
5. G. Zeppetella Sublingual fentanyl (Abstral) for breakthrough cancer pain Eur Oncol 1 2009 10 13
6. M.O. Delgado-Guay Efficacy and safety of fentanyl buccal for cancer pain management by administration through a soluble film: an update Cancer Manag Res 2 2010 303 306
7. A. Fisher, M. Watling, A. Smith, and A. Knight Pharmacokinetics and relative bioavailability of fentanyl pectin nasal spray 100-800 μg in healthy volunteers Int J Clin Pharmacol Ther 48 2010 860 867
8. S. Kaasa, K. Moksnes, and T. Nolte et al. Pharmacokinetics of intranasal fentanyl spray in patients with cancer and breakthrough pain J Opioid Manag 6 2010 17 26
9. S. Mercadante, I. Radbruch, and A. Caraceni et al. Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care Cancer 94 2002 832 839
10. G. Zeppetella, and M.D.C. Ribeiro The pharmacotherapy of cancer-related episodic pain Expert Opin Pharmacother 4 2003 493 502
11. A. Caraceni, R. Portenoy Working Group of the IASP Task Force on Cancer Pain An international survey of cancer pain characteristics and syndromes Pain 82 1999 263 274
12. G. Zeppetella, and M.D.C. Ribeiro Opioids for the management of breakthrough (episodic) pain in cancer patients Cochrane Database Syst Rev 1 2006 CD004311
13. G. Zeppetella Impact and management of breakthrough pain in cancer Curr Opin Support Palliat Care 3 2009 1 6
14. D.F. Haugen, M.J. Hjermstad, N. Hagen European Palliative Care Research Collaborative (EPCRC) Assessment and classification of cancer breakthrough pain: a systematic literature review Pain 149 2010 476 482
15. K.B. Svendsen, S. Andersen, and S. Arnason et al. Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms Eur J Pain 9 2005 195 206
16. H. Smith A comprehensive review of rapid-onset opioids for breakthrough pain CNS Drugs 26 2012 509 535
17. M.P. Davis Fentanyl for breakthrough pain: a systematic review Expert Rev Neurother 11 2011 1197 1216
18. G. Zeppetella Opioids for the management of breakthrough cancer pain in adults: a systematic review undertaken as part of an EPCRC opioid guidelines project Palliat Med 25 2011 516 524
19. B. Nicholson, and S.S. Agarwala Opioid delivery in the treatment of cancer breakthrough pain: a review of routes of administration J Opioid Manag 7 2011 69 79
20. C. Leboeuf-Yde, and J.M. Lauritsen The prevalence of low back pain in the literature. A structured review of 26 Nordic studies from 1954 to 1993 Spine 20 1995 2112 2118
21. B.F. Walker The prevalence of low back pain: a systematic review of the literature from 1966 to 1998 J Spinal Disord 13 2000 205 217
22. M.H. van den Beuken-van den Everdingen, J.M. de Rijke, and A.G. Kessels et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years Ann Oncol 18 2007 1437 1449
23. X. Gòmez-Batiste, F. Madrid, and F. Moreno et al. Breakthrough cancer pain: prevalence and characteristics in patients in Catalonia, Spain J Pain Symptom Manage 24 2002 45 52
24. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
25. W.H. Oldenmenger, P.J. de Raaf, C. de Klerk, and C.C. van der Rijt Cut points on 0-10 numeric rating scales for symptoms included in the Edmonton Symptom Assessment Scale in cancer patients: a systematic review J Pain Symptom Manage 45 2013 1083 1093
26. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
27. A. Caraceni, C. Martini, and E. Zecca Breakthrough pain characteristics and syndrome in patients with cancer pain. An international survey Palliat Med 18 2004 177 183
28. M.A. Ashby, B.G. Fleming, and M. Brooksbank et al. Description of a mechanistic approach to pain management in advanced cancer. Preliminary report Pain 51 1992 153 161
29. A. Banning, P. Sjogren, and H. Henriksen Treatment outcome in a multidisciplinary cancer pain clinic Pain 47 1991 129 134
30. S. Bhatnagar, S. Upadhyay, and S. Mishra Prevalence and characteristics of breakthrough pain in patients with head and neck cancer: a cross-sectional study J Palliat Med 13 2010 291 295
31. H. Breivik, N. Cherny, and B. Collett et al. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes Ann Oncol 20 2009 1420 1433
32. A. Caraceni, O. Bertetto, and R. Labianca Episodic (breakthrough) pain prevalence in a population of cancer pain patients. Comparison of clinical diagnoses with the QUDEI - Italian questionnaire for intense episodic pain J Pain Symptom Manage 43 2012 833 841
33. E. Chow, A. Ling, and L. Davis et al. Pain flare following external beam radiotherapy and meaningful change in pain scores in the treatment of bone metastases Radiother Oncol 75 2005 64 69
34. E. Chow, A. Loblaw, and K. Harris et al. Dexamethasone for the prophylaxis of radiation induced pain flare after palliative radiotherapy for bone metastases - a pilot study Support Care Cancer 15 2007 643 647
35. A.N. Davies, J. Vriens, A. Kennett, and M. McTaggart An observational study of oncology patients' utilization of breakthrough pain medication J Pain Symptom Manage 35 2008 406 411
36. R.H. Enting, W.H. Oldenmenger, A.R. Van Gool, C.C. van der Rijt, and P.A. Sillevis Smitt The effects of analgesic prescription and patient adherence on pain in a Dutch outpatient cancer population J Pain Symptom Manage 35 2007 523 531
37. R.L. Fainsinger, C.L. Nekolaichuk, and O.G. Lawlor et al. A multicenter study of the revised Edmonton Staging System for classifying cancer pain in advanced cancer patients J Pain Symptom Manage 29 2005 224 237
38. B.R. Fortner, T.A. Okon, and R.K. Portenoy A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without a history of breakthrough pain J Pain 3 2002 38 44
39. A. Gatti, R.D. Mediati, and C. Reale et al. Breakthrough pain in patients referred to pain clinics: the Italian pain network retrospective study Adv Ther 29 2012 464 472
40. M.T. Greco, O. Corli, and M. Montanari et al. Epidemiology and pattern of care of breakthrough cancer pain in a longitudinal sample of cancer patients: results from the cancer pain outcome research study group Clin J Pain 27 2011 9 18
41. A. Hird, E. Chow, and L. Zhang et al. Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three Canadian cancer centers Int J Radiat Oncol Biol Phys 75 2009 193 197
42. A. Holtan, N. Aass, and T. Nordoy et al. Prevalence of pain in hospitalised cancer patients in Norway: a national survey Palliat Med 21 2007 7 13
43. S.S. Hwang, V.T. Chang, and B. Kasimis Cancer breakthrough pain characteristics and responses to treatment at a VA medical center Pain 101 2003 55 64
44. I.G. Kerr, M. Sone, and C. Deangelis et al. Continuous narcotics infusion with patient-controlled analgesia for chronic cancer pain in outpatients Ann Intern Med 108 1988 554 557
45. S. Mercadante, S. Maddaloni, S. Roccella, and L. Salvaggio Predictive factors in advanced cancer pain treated only by analgesics Pain 50 1992 151 155
46. S. Mercadante, M. Armata, and L. Salvaggio Pain characteristics of advanced lung cancer patients referred to a palliative care service Pain 59 1994 141 145
47. S. Mercadante, G. Intravaia, and P. Villari et al. Intravenous morphine for breakthrough (episodic) pain in an acute palliative care unit: a confirmatory study J Pain Symptom Manage 35 2008 307 313
48. S. Mercadante, V. Zagonel, and E. Breda et al. Breakthrough pain in oncology: a longitudinal study J Pain Symptom Manage 40 2010 183 190
49. S. Mercadante, A. Valle, and S. Sabba Pattern and characteristics of advanced cancer patients admitted to hospices in Italy Support Care Cancer 21 2013 935 939
50. F. Petzke, L. Radbruch, and D. Zech et al. Temporal presentation of chronic cancer pain: transitory pains on admission to a multidisciplinary pain clinic J Pain Symptom Manage 17 1999 391 401
51. K.R. Portenoy, and N.A. Hagen Breakthrough pain: definition, prevalence and characteristics Pain 41 1990 273 281
52. R.K. Portenoy, D. Payne, and P. Jacobsen Breakthrough pain: characteristics and impact in patients with cancer pain Pain 81 1999 129 134
53. R.K. Portenoy, D. Bruns, B. Shoemaker, and S.A. Shoemaker Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part1: prevalence and characteristics J Opioid Manag 6 2010 97 108
54. C. Ripamonti, E. Fagnoni, and T. Campa et al. Decreases in pain at rest and movement-related pain during zoledronic acid treatment in patients with bone metastases due to breast or prostate cancer: a pilot study Support Care Cancer 15 2007 1177 1184
55. A.S. Strömgren, M. Groenvold, and M.A. Petersen et al. Pain characteristics and treatment outcome for advanced cancer patients during the first week of specialized palliative care J Pain Symptom Manage 27 2004 104 113
56. M. Swanwick, M. Haworth, and R.F. Lennard The prevalence of episodic pain in cancer: a survey of hospice patients on admission Palliat Med 15 2001 9 18
57. B.T. Valeberg, C. Miaskowski, and B.R. Hanestad et al. Demographic, clinical, and pain characteristics are associated with average pain severity groups in a sample of oncology outpatients J Pain 9 2008 873 882
58. G. Zeppetella, C.A. O'Doherty, and S. Collins Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice J Pain Symptom Manage 20 2000 87 92